Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
VE ›
VEZALTE
Trademark search for:
VEZALTE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-12-21 — Application filed
2011-12-24 — Application filed
2012-01-03 — Application filed
2012-03-27 — Assigned to examiner
2012-03-29 — Final disposition recorded
2012-03-29 — Final disposition recorded
2012-03-29 — Final disposition recorded
2012-07-09 — Attorney/dom.rep.revoked and/or appointed
2012-07-09 — Teas revoke/app/change addr of atty/dom rep received
2012-09-24 — Teas/email correspondence entered
2012-09-24 — Office action issued
2012-09-24 — Correspondence received in law office
2012-09-25 — Suspension letter written
2012-09-25 — Letter of suspension e-mailed
2012-09-25 — Notification of letter of suspension e-mailed
2013-03-25 — Assigned to lie
2013-03-28 — Suspension checked - to attorney for action
2013-04-01 — Suspension inquiry written
2013-04-01 — Inquiry to suspension e-mailed
2013-04-01 — Notification of inquiry as to suspension e-mailed
2013-09-25 — Teas response to suspension inquiry received
2013-09-25 — Teas/email correspondence entered
2013-09-25 — Correspondence received in law office
2013-10-03 — Approved for pub - principal register
2013-10-08 — Law office publication review completed
2013-10-23 — Notification of notice of publication e-mailed
2013-11-12 — Published for opposition
2013-11-12 — Official gazette publication confirmation e-mailed
2014-01-07 — Noa e-mailed - sou required from applicant
2014-08-11 — Application abandoned
2014-08-11 — Application abandoned
2014-08-11 — Final status recorded
Owner Information
AstraZeneca AB
Södertälje SE-151 85 SE
AstraZeneca AB
Södertälje SE-151 85 SE
Correspondent
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP 1800 Concord Pike FOP3-318 Wilmington, DE 19850-5437
Filing Details
Filing Date:
2011-12-21
Status Date:
2014-08-11
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.